Sibyl Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Kalol, Gujarat, India, established in 2020.
2020 Kalol, Gujarat, India Active
Last Updated:
Access Report
About Sibyl Pharma Llp

Sibyl Pharma Llp, a active limited liability partnership, was established on 09 September 2020 in Kalol, Gujarat, India. Engaging in api manufacturers within the pharma sector, it holds LLPIN: AAT-7510. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹2.00 Cr.

Its leadership includes Nitinchandra Savailal Shah (Designated Partner), Vipul Sumanbhai Shah (Designated Partner), Harsh Nitinbhai Shah (Designated Partner). Past directors included Sagar Dhiraj Shah. It holds ₹103.39 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at 12 Kamaldeep Industrial Estate Khatraj, Kalol, Gujarat, 382721.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAT-7510

  • Incorporation Date

    09 September 2020

  • Total Obligation of Contribution

    ₹2.00 Cr

  • ROC Code

    Roc Ahmedabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 2.00 Cr
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 103.39 Cr
Company report

Sibyl Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sibyl Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sibyl Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Nitinchandra Savailal Shah Designated Partner 09 Sep 2020 Current
Vipul Sumanbhai Shah Designated Partner 09 Sep 2020 Current
Harsh Nitinbhai Shah Designated Partner 09 Sep 2020 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sibyl Pharma Llp.

Enhance accessibility to Sibyl Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sibyl Pharma Llp revenue growth over time
Sibyl Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sibyl Pharma Llp?

Unlock access to Sibyl Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,033,900,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Bank Of India : 103.39 Cr
Latest Charge Details
Date Lender Amount Status
03 Feb 2024 Bank Of India ₹1.50 Cr Open
27 Feb 2023 Bank Of India ₹37.50 Cr Open
03 Feb 2023 Bank Of India ₹37.50 Cr Open
27 Sep 2022 Bank Of India ₹2.50 Cr Open
21 Dec 2021 Bank Of India ₹24.39 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Sibyl Pharma Llp?

Sibyl Pharma Llp has a workforce of 59 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sibyl Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sibyl Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sibyl Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Sibyl Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    The activity Sibyl Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Charges

    A charge with Bank Of India amounted to Rs. 1.50 Cr with Charge ID 100862044 was registered on 03 Feb 2024. was recorded as a recent event.

  • Charges

    The activity A charge with Bank Of India amounted to Rs. 37.50 Cr with Charge ID 100685375 was registered on 27 Feb 2023. was completed.

  • Charges

    A charge with Bank Of India amounted to Rs. 37.50 Cr with Charge ID 100684942 was registered on 03 Feb 2023. was recorded as a recent event.

  • Charges

    A charge with Bank Of India amounted to Rs. 2.50 Cr with Charge ID 100617078 was registered on 27 Sep 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Sibyl Pharma Llp?

The LLPIN of Sibyl Pharma Llp is AAT-7510.

Where is Sibyl Pharma Llp headquartered?

Sibyl Pharma Llp is headquartered at 12 Kamaldeep Industrial Estate Khatraj, Kalol, Gujarat, 382721.

When was Sibyl Pharma Llp incorporated?

Sibyl Pharma Llp was incorporated on 09 September 2020.

Who are the current directors of Sibyl Pharma Llp?

The current directors of Sibyl Pharma Llp are

What is the primary industry of Sibyl Pharma Llp?

The primary industry of Sibyl Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available